Irvine, CA, United States of America

Kendra Anita McInnis

Average Co-Inventor Count = 9.5

ph-index = 4

Forward Citations = 18(Granted Patents)

Forward Citations (Not Self Cited) = 2(Sep 21, 2024)


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Kendra Anita McInnis: Innovating Cardiac Ablation Technologies

Introduction: Kendra Anita McInnis is a distinguished inventor based in Irvine, California, recognized for her pioneering contributions in the field of cardiac ablation technologies. With a portfolio of five patents, she has significantly advanced medical procedures aimed at treating atrial fibrillation, enhancing both effectiveness and precision in cardiac care.

Latest Patents: Among her latest innovative works are two patents focusing on systems and methods for ablating cardiac tissue. The first patent discloses an ablation system that visually supports tissue ablation procedures. This system includes a display with a user interface and a processor that communicates with the display, allowing for the control of multiple electrodes on a radiofrequency balloon catheter. This setup aids in ablating targeted pulmonary veins while determining the success rate of pulmonary vein isolation (PVI) based on specific ablation parameters.

The second patent addresses the treatment of patients suffering from paroxysmal atrial fibrillation, utilizing a multi-electrode radiofrequency balloon catheter and a diagnostic catheter. The method enhances clinical effectiveness by ablating and diagnosing the targeted pulmonary veins, ensuring a sound approach to achieving isolation and effective treatment.

Career Highlights: Kendra McInnis is currently associated with Biosense Webster Ltd., a company known for its innovative solutions in electrophysiology. Her work at the company reflects a commitment to improving patient outcomes through advanced medical technology.

Collaborations: In her professional journey, Kendra has collaborated with notable colleagues including Nader Ghaly and Moe Habib Bishara. These partnerships have been instrumental in furthering research and development in the field of cardiac procedures.

Conclusion: Kendra Anita McInnis stands out as a leading innovator in the medical field, particularly in cardiac ablation technologies. Her contributions through multiple patents underscore her dedication to improving healthcare solutions for patients with atrial fibrillation. With her ongoing work and collaborations, she continues to play a crucial role in transforming cardiac care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…